LQDA, US53635D2027

Twelve analysts set USD 72.85 target for Liquidia stock

Published on 10/24/2026 at 20:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Liquidia booked USD 171.68 million revenue in second-quarter 2026. Liquidia stock costs EUR 37.70 on October 24, 2026 at 1:04 p.m. CEST.

Analyst target and reporting date

Twelve analysts had an average 12-month Liquidia target of USD 72.85 on October 23, 2026.
Second-quarter 2026 revenue reached USD 171.68 million, up 1,842.10 percent year over year.
Liquidia stock costs EUR 37.70 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST.
Liquidia is scheduled to report September 2026 results on November 2, 2026.

LQDA, US53635D2027, Illustration mit AI erstellt.

Liquidia Corporation (ISIN US53635D2027) had an average 12-month analyst target of USD 72.85 from 12 analysts as of October 23, 2026. MarketBeat reported a consensus Hold rating, with five Buy, one Strong Buy, four Hold and two Sell ratings. The target stands 70.81 percent above the USD 42.65 Nasdaq price dated October 23, 2026. Liquidia was trading at EUR 37.70 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST.

Revenue reached USD 171.68 million

Liquidia reported USD 171.68 million in revenue for the second quarter of 2026, compared with USD 168.48 million in the consensus estimate. Revenue increased 1,842.10 percent from the second quarter of 2025, while diluted earnings per share came in at USD 0.74 against a USD 0.76 consensus estimate, a shortfall of USD 0.02. These figures were reported in the October 23, 2026 MarketBeat review, which also identified the company as listed on Nasdaq.

Cash and product execution matter

The company reported USD 284.18 million in cash and cash equivalents as of June 30, 2026. Its website describes a business focused on inhaled therapies for rare cardiopulmonary diseases, including pulmonary arterial hypertension, and identifies YUTREPIA as a lead product. Liquidia also highlights its proprietary PRINT technology for engineering drug particles and delivery methods.

Next report arrives November 2

Liquidia is scheduled to report September 2026 results on November 2, 2026, with the report date listed by MetaCap. The same listing identifies Nasdaq as the primary exchange, a USD 22.05 to USD 93.61 52-week range and a USD 3.8 billion market capitalization as of October 24, 2026. The coming report will give investors a fresh operating-period comparison after the second-quarter revenue increase.

Price and valuation remain separate

Liquidia's latest US quotation was USD 42.65 on Nasdaq on October 23, 2026 at 4:00 p.m. ET, while the German-market indication was EUR 37.70 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST. The two currencies describe separate venues and are not combined in the same performance calculation. The analyst target, second-quarter revenue and November reporting date provide the main reference points for the stock report.

Trading perspective

The current picture combines a USD 72.85 average analyst target with second-quarter revenue of USD 171.68 million and a scheduled November 2 report. The next results will show whether the company can extend the operating scale reflected in its second-quarter figures. The further course of trading is shown by the continuously updated real-time quote of Liquidia stock.